New Antibiotics and Bacterial Resistance

Rational prescribing in pediatric infection
  • Sheldon L. Kaplan
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 549)


Antibiotic resistance for many pediatric pathogens has been increasing steadily over the past decades and has complicated the antibiotic management of both community- and hospital acquired infections. This review will focus on two Gram-positive organisms- Staphylococcus aureus and Streptococcus pneumoniae and selected Gram-negative organisms that are important nosocomial organisms.


Pneumococcal Conjugate Vaccine Vancomycin Resistant Enterococcus ESBL Produce Invasive Pneumococcal Infection Heptavalent Pneumococcal Conjugate Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Black, S., Shinefield, H., Fireman, B., Lewis, E., Ray, P., Hansen, J.R. et al., and the Northern California Kaiser Permanente Vaccine Study Center Group. (2000). Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 19, 187–195.PubMedCrossRefGoogle Scholar
  2. Chow, J.W., Fine, M.J., Shlaes, D.M., Quinn, J.P., Hooper, D.C., Johnson, M.P. et al. (1991). Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy. Ann. Intern. Med. 115, 585–590.PubMedGoogle Scholar
  3. Herold, B.C., Immergluck, L.C., Maranan, M.C., Lauderdale, D.S., Gaskin, R.S., Boyle-Varva, S. et al. (1998). Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. J.A.M.A. 279, 593–598.PubMedCrossRefGoogle Scholar
  4. Kaplan, S.L., Deville, J.G., Yogev, R., Morfin, M.R., Wu, E., Adler, S. et al., and the Linezolid Pediatric Study Group. (2003a). Linezolid versus vancomycin in the treatment of resistant Gram-positive infections in children. Pediatr. Infect. Dis. J. 22, 677–685.PubMedCrossRefGoogle Scholar
  5. Kaplan, S.L. and the United States Pediatric Multicenter Pneumococcal Surveillance Group. (2003b). Decline in invasive Streptococcus pneumoniae infections in eight children’s hospitals, Pediatr. Res. 53:565A. Abstract 3199.Google Scholar
  6. Loeffler, A.M., Drew, R.H., Perfect, J.R., Grethe, N.I., Stephens, J.W., Gray, S.L., and Talbot, G.H. (2002). Safety and efficacy of quinupristin/dalfopristin for the treatment of invasive gram-positive infections in children. Pediatr. Infect. Dis. J. 21, 950–956.PubMedCrossRefGoogle Scholar
  7. Martinez A.G., Hammerman, W., Mason, E.O. Jr., and Kaplan, S.L. (2003). Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr. Infect. Dis. J. 7, 593–598.Google Scholar
  8. Patterson, D.L., Ko W.-C., Von Gottberg, V., Casellas, J.M., Mulazimoglu, L., Klugman, K.P. et al. (2001). Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum ß-lactamases: Implications for the clinical microbiology laboratory. J. Clin. Microbiol. 39, 2206–2212.CrossRefGoogle Scholar
  9. Sattler, C.A., Mason, E.O. Jr., and Kaplan, S.L. (2002). Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr. Infect. Dis. J. 21, 910–915.PubMedCrossRefGoogle Scholar
  10. Whitney, C.G., Farley, M.M., Hadler, J., Harrison, L.H., Bennett, N.M., Lynfield, R. et al., and Schuchat, A. for the Active Bacterial Core Surveillance of the Emerging Infections Program Network. (2003). Decline in invasive pneumococcal disease after the introduction of protein-conjugate polysaccharide conjugate vaccine. N. Engl. J. Med. 348, 1737–1746.PubMedCrossRefGoogle Scholar

Copyright information

© Science+Business Media New York 2004

Authors and Affiliations

  • Sheldon L. Kaplan

There are no affiliations available

Personalised recommendations